Hollencrest Capital Management’s Ascendis Pharma A/S ASND Stock Holding History

Hollencrest Capital Management’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.8K	Hold	48	–	–	﹤0.01%	791
2026 Q1	$11K	Hold	48	–	–	﹤0.01%	816
2025 Q4	$10.2K	Hold	48	–	–	﹤0.01%	815
2025 Q3	$9.54K	Hold	48	–	–	﹤0.01%	804
2025 Q2	$8.29K	Hold	48	–	–	﹤0.01%	799
2025 Q1	$7.48K	Hold	48	–	–	﹤0.01%	817
2024 Q4	$6.61K	Hold	48	–	–	﹤0.01%	854
2024 Q3	$7.17K	Hold	48	–	–	﹤0.01%	811
2024 Q2	$6.55K	Buy	48 +10	+26%	+$1.36K	﹤0.01%	795
2024 Q1	$5.74K	Buy	+38	New	+$5.42K	﹤0.01%	789

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Hollencrest Capital Management's ASND Position: Q2 2026 in Review

Hollencrest Capital Management held its Ascendis Pharma A/S (ASND) position steady in Q2 2026 at 48 shares worth $12.8K. The position accounts for ﹤0.01% of the portfolio, ranked #791.

Hollencrest Capital Management first reported a position in ASND in Q1 2024 and has held it in 10 quarters since. 311 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Hollencrest Capital Management held 48 shares of Ascendis Pharma A/S worth $12.8K as of Q2 2026.
Hollencrest Capital Management left its Ascendis Pharma A/S share count unchanged in Q2 2026.
Ascendis Pharma A/S made up ﹤0.01% of Hollencrest Capital Management's portfolio in Q2 2026, its #791 holding.
Hollencrest Capital Management first reported a position in Ascendis Pharma A/S in Q1 2024 and has held it in 10 quarters since.
311 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Hollencrest Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.